Track Mariannette's sponsored bills, co-sponsored legislation, and voting record
This Act updates the definition of fossil fuel under the Clean Air Act to specifically include fuel used by ocean-going vessels, paving the way for new renewable fuel standards for the shipping industry.
Mariannette Miller-Meeks
Representative
IA
Mariannette Miller-Meeks
Representative
IA
This Act updates the definition of "fossil fuel" under the Clean Air Act to specifically include fuel used by ocean-going vessels. This change allows the EPA to incorporate maritime fuel into renewable fuel standards moving forward. The EPA is required to finalize the necessary regulations within one year of the bill's enactment.
This act requires lobbyists to disclose the specific foreign government or political party that directs, plans, supervises, or controls their lobbying activities.
Mariannette Miller-Meeks
Representative
IA
Mariannette Miller-Meeks
Representative
IA
The Disclosing Foreign Influence in Lobbying Act amends the Lobbying Disclosure Act of 1995 to enhance transparency regarding foreign influence in lobbying activities. This legislation mandates that lobbyists must now disclose the name and address of any foreign government or political party that directs, plans, supervises, or controls their lobbying efforts. This ensures the public and regulators are aware of foreign entities influencing domestic lobbying work.
Allows individuals to enroll in standalone dental plans through the Health Insurance Exchange, regardless of health plan enrollment status.
Mariannette Miller-Meeks
Representative
IA
Mariannette Miller-Meeks
Representative
IA
The "Increasing Access to Dental Insurance Act" aims to broaden access to dental coverage by enabling individuals to enroll in standalone dental plans via the Health Insurance Exchange, irrespective of their enrollment status in a qualified health plan. This expands options for individuals seeking dental insurance.
The "Alternatives to PAIN Act" aims to improve Medicare Part D coverage for non-opioid pain management drugs by reducing cost-sharing and removing barriers like step therapy and prior authorization, starting in 2026.
Mariannette Miller-Meeks
Representative
IA
Mariannette Miller-Meeks
Representative
IA
The "Alternatives to PAIN Act" amends Medicare Part D to improve access to non-opioid pain management drugs by waiving deductibles and ensuring they are placed on the lowest cost-sharing tier starting in 2026. The Act also prohibits the use of step therapy and prior authorization requirements for these drugs, further easing access for patients. These changes aim to provide more accessible alternatives for pain management, reducing reliance on opioids.
The bill requires the Secretary of Health and Human Services to create and regularly update a plan for the rapid development, validation, production, and distribution of diagnostic tests in response to public health emergencies.
Mariannette Miller-Meeks
Representative
IA
Mariannette Miller-Meeks
Representative
IA
The "Diagnostics Testing Preparedness Plan Act of 2025" requires the Secretary of Health and Human Services to develop and regularly update a plan for the rapid development, validation, production, and distribution of diagnostic tests in response to public health emergencies. This plan aims to improve coordination between public and private entities, consider new technologies, address medical supply needs, and ensure efficient test distribution. The Secretary is authorized to contract with public and private entities to enhance domestic diagnostic testing capacity and must release the plan within one year, updating it every three years thereafter.
The "Medicaid Program Improvement Act" requires states to verify Medicaid enrollee addresses through reliable data sources and mandates managed care entities to transmit address information to the state, starting January 1, 2026.
Mariannette Miller-Meeks
Representative
IA
Mariannette Miller-Meeks
Representative
IA
The "Medicaid Program Improvement Act" requires states to verify Medicaid enrollees' address information regularly through reliable data sources starting January 1, 2026. It also mandates that managed care entities share address information received from or verified with enrollees to the state. This aims to improve the reliability of address information within the Medicaid program.